Financial statements Captor Therapeutics
Balance sheet of Captor Therapeutics
Company age:
Age:
7 y. 1 m. 26 d.
Share capital:
Share capital:
359 000 PLN
Balance sheet data of CAPTOR THERAPEUTICS
|
Year
|
2018
|
2019
|
|---|---|---|
| Total assets | 14 493 672,36 | 22 663 185,62 |
| A. Fixed assets | 5 981 933,13 | 4 751 159,21 |
| B. Current assets | 8 509 014,83 | 17 912 026,41 |
| C. Share capital contributions (basic funds) | 2 724,40 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 14 493 672,36 | 22 663 185,62 |
| A. Equity | 4 700 204,02 | 4 377 988,52 |
| B. Liabilities and provisions for liabilities | 9 793 468,34 | 18 285 197,10 |
| I. Long-term liabilities | 4 864 927,95 | 3 577 216,78 |
| II. Short-term liabilities | 3 577 854,19 | 4 233 767,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.